Unhealthy days and quality of life in Irish patients with diabetes by Clifford, Emma L. et al.
Title Unhealthy days and quality of life in Irish patients with diabetes
Author(s) Clifford, Emma Louise; Collins, Margaret M.; Buckley, Claire M.;
Fitzgerald, Anthony P.; Perry, Ivan J.
Publication date 2013
Original citation Clifford EL, Collins MM, Buckley CM, Fitzgerald AP, Perry IJ (2013)
Unhealthy Days and Quality of Life in Irish Patients with Diabetes.
PLoS ONE 8(12): e81102. doi:10.1371/journal.pone.0081102
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://dx.doi.org/10.1371/journal.pone.0081102
Access to the full text of the published version may require a
subscription.
Rights © 2015 Clifford et al. This is an open access article distributed under
the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited
http://creativecommons.org/licenses/by/4.0/
Item downloaded
from
http://hdl.handle.net/10468/2349
Downloaded on 2017-02-12T12:54:58Z
Unhealthy Days and Quality of Life in Irish Patients with
Diabetes
Emma Louise Clifford1,3*, Margaret M. Collins2, Claire M. Buckley3, Anthony P. Fitzgerald3,4, Ivan J. Perry3
1Department of Nutrition & Dietetics, South Infirmary Victoria University Hospital, Cork, Ireland, 2University of California Co-Operative Extension, Sonora, California,
United States of America, 3Department of Epidemiology & Public Health, University College Cork, Cork, Ireland, 4Department of Statistics, University College Cork, Cork,
Ireland
Abstract
Objectives: To study the determinants of health-related quality of life (HRQoL) in Irish patients with diabetes using the
Centres for Disease Controls’ (CDC’s) ‘Unhealthy Days’ summary measure and to assesses the agreement between this
generic HRQoL measure and the disease-specific Audit of Diabetes Dependant Quality of Life (ADDQoL) measure.
Research Design and Methods: Data were analysed from the Diabetes Quality of Life Study, a cross-sectional study of 1,456
people with diabetes in Ireland (71% response rate). Unhealthy days were assessed using the CDC’s ‘Unhealthy days’
summary measure. Quality of life (QoL) was also assessed using the ADDQoL measure. Analyses were conducted primarily
using logistic regression. The agreement between the two QoL instruments was measured using the kappa co-efficient.
Results: Participants reported a median of 2 unhealthy days per month. In multivariate analyses, female gender (P = 0.001),
insulin use (P = 0.030), diabetes complications (P =,0.001) were significantly associated with more unhealthy days. Older
patients had fewer unhealthy days per month (P = 0.003). Agreement between the two measures of QoL (unhealthy days
measure and ADDQoL) was poor, Kappa = 0.234
Conclusions: The findings highlight the determinants of HRQoL in patients with diabetes using a generic HRQoL summary
measure. The ‘Unhealthy Days’ and the ADDQoL have poor agreement, therefore the ‘Unhealthy Days’ summary measure
may be assessing a different construct. Nonetheless, this study demonstrates that the generic ‘Unhealthy Days’ summary
measure can be used to detect determinants of HRQoL in patients with diabetes.
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Introduction
The prevalence of diabetes is rising globally, with the number of
people with diabetes increasing from 153 (127–182) million in
1980, to 347 (314–382) million in 2008 [1]. Improving quality of
life (QoL) is one of the major goals in the St. Vincent Declaration
for people with diabetes [2]. Patients with poor quality of life
(QoL) are less likely to comply with their dietary regime, be
physically active and manage diabetes self-care. There have been
numerous instruments developed over the years to measure QoL
and health related quality of life (HRQoL) leading to on-going
debate on whether generic or disease-specific measures have
greater relative merit. Generic instruments, such as the Short-
Form-36 (SF-36) [3–6], EuroQoL (EQ-5D) [5,7–8] and the
Centres of Disease Control’s (CDC’s) HRQoL-4 measures [9–11]
have been used in the literature on patients with diabetes.
Examples of diabetes disease-specific instruments most widely used
are the Audit of Diabetes Dependant Quality of Life (ADDQoL)
[3–5], Diabetes Quality of Life Questionnaire (DQOL) [6], and
the Problem Areas in Diabetes Scale (PAID) [6].
Several studies have identified predictors of HRQoL in diabetes
using both generic and disease-specific instruments [3,5–6,8–15].
Overall, the most significant determinants of poor HRQoL are
insulin use [5,8,10], obesity [3,5,8] and diabetes related compli-
cations, [3,8,13–14,16]. Specifically, studies using the generic
CDC’s HRQoL-4 measures have shown that having diabetes is
associated with poor physical health [11,17] and poor mental
health [11]. Cross-sectional studies using the ADDQoL have also
shown that patients with diabetes have poor QoL [3–5], especially
those that are obese [3,8], those with type 1 diabetes [4], those
using insulin [3–4,8,10], and those with diabetes related compli-
cations [3–4,8]. Notably, QoL has been found to be better in older
people using disease specific instruments (ADDQoL, DQOL,
PAID, ADS) [4,5,6]. A substantial body of literature has focused
on comparing generic and disease-specific measures [3,7,12,18–
21]. Disease-specific instruments focus on a population with a
specific disease e.g. diabetes, asthma or rhinitis and their
advantage is that they are more responsive to treatment related
change [22–24]. Generic instruments are designed to investigate
aspects of health that are of universal importance [21] and are
applicable to both healthy people and those with disease and are
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therefore more generalizable [20]. Rubin & Peyrot suggest that
using both generic and disease-specific instruments provides a
more comprehensive assessment of HRQoL in patients with
diabetes [14]. The generic CDC’s healthy days measures are a set
of measures of health status and activity limitation [25]. The
HRQoL-4 measures are four core measures of the healthy days set
and are widely used in the U.S. [25]. The ‘unhealthy days’
summary measure is based on the second and third questions of
the HRQoL-4 and it estimates the overall number of recent days
when physical or mental health was not good [25]. Experience in
using this instrument in patients with diabetes is limited and few
published studies have specifically examined determinants of
HRQoL in diabetes using these measures. Moreover, studies using
the CDC’s ‘unhealthy days’ summary measure as an instrument to
measure HRQoL is very limited.
Our aim was to study the determinants of HRQoL in Irish
patients with diabetes using CDC’s ’unhealthy days’ summary
measure. We also address the level of agreement between this
generic HRQoL measure and the ADDQoL, an established
disease-specific instrument in the measurement of QoL in these
patients.
Research Design and Methods
Data were collected from the Diabetes Quality of Life Study,
which is a cross-sectional study involving 2,049 Irish people aged
20 to 75 years with a confirmed diagnosis of type 1 or 2 diabetes
(71% response rate) [4,26]. Patients were recruited from those
attending three different models of diabetes care in Ireland. The
self-completed questionnaire addressed standard demographic,
social and clinical factors including sex, age, educational and
marital status, type of diabetes, insulin use, body mass index (BMI)
and diabetes related complications. Details of the methodology
and recruitment are available elsewhere [4,26–27].
Ethics Statement
The study was approved by the Clinical Research Ethics
Committee of the Cork Teaching Hospitals and the Irish College
of General Practitioners (ICGP) Ethics Committees. All patients
gave written informed consent.
Generic HRQoL instrument: Centres for Disease Controls’
‘Unhealthy Days’ Summary Measure [28]
HRQoL was assessed using the ‘unhealthy days’ summary
measure from the CDC’s HRQoL-4 core Healthy Days measures
[28]. These four measures are the briefest set of validated generic
HRQoL measures, based on understandable and clear definition
of HRQoL [25,28–29]. They were derived from the original
version of the Medical Outcomes Study 36-item short-from survey
(SF-36) instrument [9,28–30] and have been validated in both
healthy and disabled populations with acceptable criterion validity
and reliability comparable with multiple item SF-36 subscales
[9,25,28–30]. They are used yearly in the Behavioural Risk Factor
Surveillance System (BRFSS) telephone survey in the U.S. [28].
Based on average times, the HRQoL-4 takes about 1.0 minute to
administer via telephone [28]. The four questions include: 1) self-
rated health, (poor, fair, good, very good, excellent) 2) number of
recent days when physical health was not good, (0–30days) 3)
number of recent days when mental health was not good (0–30
days) and 4) number of recent days that poor physical or mental
health kept you from doing your usual work or recreational
activities (0–30 days). Recent is defined as during the previous 30
days [28]. Unhealthy days are an estimate of the overall number of
days during the previous 30 days when the respondent felt that
they had poor physical or mental health. For the purpose of this
research, we focused on total unhealthy days (unhealthy days
summary measure), which is the sum of the number of days of
poor physical health (question 2) and poor mental health (question
3), with a logical maximum of 30 unhealthy days per month [28].
The unhealthy day’s summary measure provides a simple
assessment of perceived physical and mental health over time,
with good concurrent and acceptable criterion validity [25,28–30].
The more unhealthy days reported per month, the poorer the
HRQoL.
Disease-specific instrument: Audit of Diabetes
Dependant Quality of Life (ADDQoL) [31]
QoL was also measured using the ADDQoL 18 item instrument
which is an established disease-specific instrument measuring the
impact of diabetes upon the individual [31]. The ADDQoL is a
well-recognised QoL measurement tool with good psychometric
properties and it is now translated into twenty languages [32,33].
It measures the impact of diabetes on 18 items representing
domains of life: work, family, sex and social life, finances, physical
appearance, physical activities, travel, self-confidence, motivation,
dependence, living conditions, society reaction, future, freedom to
eat and drink and enjoyment of food. Scores are on a scale of +9 to
29, the more negative the score, the greater the impact of diabetes
on QoL, therefore poorer QoL.
Statistical Analyses
The principle analyses of the data focused on the association
between the unhealthy day’s summary measure and socio-
demographic and clinical variables in patients with diabetes. We
dichotomised the unhealthy days (days 0 to 30), and used the
reporting of no unhealthy days (none) per month vs. reporting of one
or more unhealthy days (1–30) per month. Non-parametric Mann-
Whitney U test and the Kruskal-Wallis test were used to compare
the median number of unhealthy days in different patient
subgroups. Binary logistic regression analysis was used to assess
whether the reporting of unhealthy days was independently
associated with any of the socio-demographic or clinical variables.
The recoded unhealthy day’s measure (none vs. one or more) was used
as the dependant variable. The prevalence odds ratio (OR’s) and
95% Confidence Intervals were estimated for the reporting of
unhealthy days. It was first run adjusted for gender and age only,
then fitted with the all categorical variables and re-run adjusting
for confounders. The relationship between the ADDQoL score
(29 to +9) and the unhealthy days summary measure (0–30 days)
was explored using Spearman’s Rank Order Correlation. Agree-
ment between these measures of QoL was also assessed using the
Kappa statistic. The data were dichotomised prior to these
analyses: ADDQoL score in the upper quartile vs. quartiles 1–3
[4], and the unhealthy days: reporting of none vs. one or more. Kappa
coefficient assesses inter-rater agreement between two instruments
on a scale of 0 to 1 [34]. Data analyses were conducted using SPSS
version 18.0 for Windows.
Results
Participants
The overall response rate was 71% (N=1456). The sample was
composed of 42.1% females. Over half (53.6%) of participants
were in the 60+ year’s age category. Almost 80% (n= 1160) had
type 2 diabetes and 62.2% (n= 721) with of those with type 2
diabetes were aged 60+ years. Only 23% of participants aged 60+
years had type 1 diabetes. Of those with type 2 diabetes, only
17.8% (n= 179) were using insulin. Almost a third (32.3%) of
Health Related Quality of Life in Diabetes
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e81102
subjects had a BMI of .30 kg/m2. We found that Irish patients
with diabetes reported a median of 2 (IQR 0–10) unhealthy days
in the past month and diabetes impacts negatively on QoL, with
an ADDQoL score of 21.7 (IQR 23.56 to 20.65). Almost half of
participants, reported no unhealthy days per month (n= 624,
49%), with 51% (n= 649) reporting one or more unhealthy days
per month. Table 1 summarises the findings from univariate
analysis of unhealthy days by age, gender, socio-demographic and
clinical variables. Older age (P= 0.001) and married status (0.047)
were significantly associated with fewer unhealthy days in the past
month. Female gender (P=,0.001) was associated with an
increased number of unhealthy days. There was no significant
difference in age between males (median 60 years) and females
(median 61 years) (P = 0.57). Insulin use was associated with
having more unhealthy days per month (P = 0.035). Having
diabetes complications increased the number of unhealthy days
per month (P=,0.001). Almost half of females (n = 295, 48.2%)
had two or more complications but there was no significant
difference in the number of complications between males and
females (P = 0.44). There was no significant difference when
comparing mean BMI of males and females (P = 0.59). Type of
diabetes and educational status were not significantly associated
with reporting unhealthy days and there was no significant
association between gender and educational status (P = 0.12)
We found significant difference in mean BMI between those
reporting no unhealthy days per month (27.4 kg/m2) and those
reporting one or more unhealthy days per month (28.4 kg/m2)
(P = 0.02). The mean difference was 0.96 kg/m2, [CI 0.14–1.75].
A Kruskal-Wallis was conducted to explore the impact of BMI on
the number of reported unhealthy days. We dichotomised BMI
again into three categories: healthy (BMI ,24.9 kg/m2), over-
weight (BMI 25–29.9 kg/m2) and obese (.30 kg/m2). There was
a statistically significant difference in reporting of unhealthy days
across the three categories (P =,0.001). The median number of
unhealthy days reported was 2 days for BMI,24.9 kg/m2, 0 days
for BMI 25–29.9 kg/m2 and 3 days for those with a BMI of
30+kg/m2, and the difference was statistically significant across all
three groups (P=,0.001).
Logistic Regression
Table 2 summarises the findings from logistic regression
analyses on the determinants of unhealthy days. After adjustment
for age, females were more likely to report one or more unhealthy
days [OR 0.74, CI 0.56–0.88, p = 0.002]. After adjustment for
gender, participants aged 60+years were less likely to report
unhealthy days [OR 0.64, CI 0.43–0.95, p = 0.028]. After
adjustment for age and gender only; types of diabetes, educational
status, marital status, insulin use or BMI were not significantly
associated with unhealthy days. Those with two or more diabetes
complications were more likely to report unhealthy days [OR
2.71, CI 2.04–3.60, p =,0.001]. In multivariate analyses, female
gender continued to be predictive for reporting one or more
unhealthy days [OR 0.66, CI 0.51–0.84, p = 0.001]. The chances
of reporting one or more unhealthy days decreased with older age
Table 1. Distribution of Unhealthy Days by socio-demographic and clinical variables (N = 1456).
Variable *N (%)
Median (IQR) (unhealthy days
summary index) **p-value
Gender: Male 842 (57.9) 0 (0–9) ,0.001
Female 612 (42.1) 3 (0–14)
Age: 20–39 years 121 (8.4) 3 (0–9) 0.001
40–59 years 546 (38) 2 (0–13)
60+ years 768 (53.6) 0 (0–10)
Type: Type 1 296 (20.3) 2 (0–8.5) 0.87
Type 2 1160 (79.9) 1 (0–11)
Education: Primary 601 (41.3) 1 (0–10) 0.62
Lower Secondary 339 (23.3) 2 (0–9.5)
Completed Secondary 227 (16.6) 1 (0–7)
Tertiary 180 (12.4) 2 (0–10)
Unknown 63 (4.3) 1 (0–23)
Marital Status: Married 966 (66.3) 1 (0–10) 0.05
Unmarried 477 (32.8) 2 (0–15)
Insulin Use: Yes 462 (31.7) 2 (0–10) 0.04
No 828 (56.9) 0 (0–10)
Diabetes Complications: None 408 (28) 0 (0–5) ,0.001
One 342 (23.5) 1 (0–8)
Two or more 706 (48.5) 4 (0–16.5)
BMI: ,24.9 kg/m2 371 (26.2) 2 (0–10) ,0.001
25–29.9 kg/m2 572 (40.4) 0 (0–7.5)
.30 kg/m2 474 (33.5) 3 (0–14)
*Number (N) for individual variables will vary because of missing values.
**P value obtained with Mann-Whitney U test or Kruskal Wallis test as appropriate.
BMI = body mass index.
doi:10.1371/journal.pone.0081102.t001
Health Related Quality of Life in Diabetes
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[OR 0.45, CI 0.26–0.77, p = 0.004]. Those using insulin were
more likely to report unhealthy days [OR 1.52, CI 1.04–2.22,
p = 0.030]. The chances of reporting unhealthy days increased
almost threefold in those with two or more complications [OR
2.75, CI 1.99–3.77, p =,0.001]. Those with a BMI of 25–
29.9kg/m2 were less likely to report unhealthy days [OR 0.71, CI
0.52–0.99, p = 0.04]. Types of diabetes, educational and marital
status were not significantly associated with unhealthy days.
Agreement between measures
The relationship was explored using Spearman’s Rank Order
Correlation. There was a medium, negative correlation between
the ADDQoL scores and the number of unhealthy days (0–30),
r =20.368, P =,0.001, with a higher number of unhealthy days
associated with a lower ADDQoL score. There was ‘poor
agreement’ between the ADDQoL scores (4th versus 1st to 3rd
quartile) and unhealthy days (none vs. one or more), with a kappa
coefficient of 0.234. Figure 1 shows the variability of the ADDQoL
score within the dichotomised unhealthy day’s groups. While the
distribution of the ADDQoL scores was shifted to lower levels in
those with one or more unhealthy days relative to those with none,
there was significant overlap between the two groups.
Discussion
This study provides a better understanding on the determinants
of HRQoL in diabetes and is the one of the first published studies
to use the generic CDC’s unhealthy day’s summary measure on
patients with diabetes. We found female gender, insulin use and
diabetes complications to be significantly associated with poor
HRQoL. We found that older patients to have significantly better
HRQoL. Surprisingly, we found that being overweight was
significantly associated with reporting no unhealthy days when
compared to being a healthy weight or obese. Additionally, we
tested the hypothesis that there would be an association between
the unhealthy day’s summary measure and the disease-specific
ADDQoL instrument. We found that the shorter unhealthy day’s
summary measure could not be used as an independent predictor
of ADDQoL scores; however it is sensitive enough to detect the
determinants of HRQoL in patients with diabetes.
Collins et al, in the same study population, found individuals
who were 60+ years of age reported higher ADDQoL scores than
those who were younger (20–59 years). Insulin use and diabetes
complications were significantly associated with lower ADDQoL
scores, similar to our findings on the same patient group [4].
The findings from this study can be compared with results from
other countries. We found that Irish patients with diabetes
reported a median of 2 unhealthy days in the past month.
Prevalence estimates of mean unhealthy days in the U.S. general
population in 2010 were 6.2 unhealthy days per month, using the
BRFSS trend data [35]. Brown et al., examined adults with
diabetes using data from the 2001 BRFSS in the U.S, and found
the mean number of physically or mentally unhealthy days were
9.7 [10]. Campbell et al. used data from the 2005 BRFSS, and
having diabetes was associated with an average of 9 days of poor
physical health and 4.6 days of poor mental health in the previous
month [10]. The disparity in reporting of unhealthy days between
Ireland and the U.S. is difficult to understand and unfortunately
data on unhealthy days in the general Irish population are
unavailable. However, a recent survey carried out by the
Organisation for Economic Co-operation and Development
(OECD) across 34 countries measuring well-being, ranks Ireland
among the top ten countries with better overall well-being using a
‘better life index’[36]. This may explain our findings on the
reporting low unhealthy days.
Consistent with previous research using generic instruments, we
found female gender to be a significant predictor for reporting
unhealthy days, therefore poor HRQoL [8,15]. This may be due
to women’s role in society, with multiple responsibilities, juggling
work-life, family-life and their diabetes regimen. We found those in
the 60+ age group to have less unhealthy days, therefore better
HRQoL, compared to their younger counterparts. This is
consistent with Trief et al., who found that elderly adults with
diabetes reported better social functioning, using the SF-36 and
Table 2. Determinants of Unhealthy Days (one or more unhealthy days in the past month) in patients with types 1 and 2 diabetes.
Determinants of Unhealthy Days OR* CI (95%) p-value OR** CI (95%) p-value
Sex: Male vs. Female 0.74 0.56–0.88 0.002 0.66 0.51–0.84 0.001
Age: 40–59 yrs vs. 20–39 yrs 0.96 0.63–1.45 0.84 0.79 0.48–1.29 0.35
Age: 60+ yrs vs. 20–39 yrs 0.64 0.43–0.95 0.03 0.45 0.26–0.77 0.004
Type: Type 2 vs. Type 1 0.94 0.66–1.24 0.53 0.71 0.44–1.14 0.16
Education: lower secondary vs. primary 0.91 0.68–1.22 0.52 1.07 0.77–1.50 0.69
Education: completed secondary vs. primary 0.84 0.60–1.17 0.31 1.04 0.71–1.51 0.84
Education: tertiary vs. primary 1.14 0.79–1.64 0.49 1.37 0.91–2.16 0.13
Education: unknown vs. primary 0.98 0.53–1.78 0.94 1.07 0.53–2.15 0.85
Marital status: married vs. unmarried 1.23 0.96–1.55 0.93 1.12 0.93–1.60 0.15
Insulin use: insulin vs. no insulin use 1.27 0.98–1.65 0.07 1.52 1.04–2.22 0.03
Diabetes Complications: One vs. none 1.67 1.2–2.30 0.002 1.77 1.24–2.53 0.002
Diabetes Complications: two or more vs. none 2.71 2.04–3.60 ,0.001 2.75 1.99–3.77 ,0.001
BMI: 25–29.9 kg/m2 vs. ,24.9 kg/m2 0.78 0.58–1.03 0.08 0.71 0.52–0.99 0.04
BMI: .30 kg/m2 vs. ,24.9 kg/m2 1.28 0.95–1.72 0.11 1.12 0.76–1.58 0.56
Reference group in Italics.
*Logistic regression model for each variable, adjusted for age and sex only.
**Logistic regression model adjusted for age, sex and all other variables in the table.
BMI = body mass index.
doi:10.1371/journal.pone.0081102.t002
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significantly less diabetes-related emotional distress using the
PAID [6]. Sundaram et al. found that older age significantly
explained higher MCS-12 scores indicating better mental health
status [5]. Our findings are contradictory to the Brown et al. study;
they found older adults with diabetes reporting nearly twice as
many unhealthy days, but they categorised older adults as .50
years [10]. It can be argued that the unhealthy day’s summary
measure picked up more general issues around physical and
emotional stress which may be higher in the younger age groups,
with the general demands of life. Few of our older patients with
type 2 diabetes were using insulin. It is possible that some of these
patients may have been recently diagnosed with diabetes and may
not have progressed to having diabetes complications or to require
insulin for good glycaemic control. This suggests that insulin use is
a burden on quality of life in diabetes. In the present study, insulin
use was significantly associated with reporting unhealthy days. Our
findings concur with research using both generic and disease-
specific measures; where insulin use was associated with poorer
scores on the ADDQoL [3,4,5,12], EQ-5D [3], SF-12, [3,8] and
more unhealthy days per month [10]. Our findings complement
the research consensus on the negative association between
diabetes complications and QoL [3,4,8]. We found significant
associations between unhealthy days and increasing number of
complications. However, our study did not differentiate between
the severities of the complications reported. Future studies should
include ranking the severity of complications with HRQoL. We
found that having a BMI between 25–29.9 kg/m2 (overweight)
was protective of reporting unhealthy days when compared to
being a healthy weight or obese. We did not find any association
between obesity (BMI.30 kg/m2) and unhealthy days which was
has been found in previous work using both generic and disease-
specific instruments [3,5,8]. It can be hypothesised that obesity can
contribute to poor mobility and more psychological issues,
including depression, which the unhealthy days summary measure
may have detected here but the causal relationship of this cannot
be established.
The unhealthy days summary measure in this study and the
ADDQoL used in the same population [4] have identified similar
determinants of poor QoL. Despite this finding, the Kappa
coefficient demonstrated poor agreement between the two
measures. Our study is one of the first studies to examine
agreement between these two measures, and this finding would
suggest that the unhealthy days summary measure and the
ADDQoL maybe measuring different constructs. Perhaps this is
due to the CDC’s HRQoL-4 being derived from the SF-36 which
is a measurement of health status, which is a distinctly different
construct to QoL, which the ADDQoL measures.
Limitations of the study include the cross-sectional design,
which limits causal inference due to uncertainty around the
direction of associations. The unhealthy days summary measure
ranges from 0–30 days and we may have lost statistical power by
collapsing into response categories (one or more vs. none). Our
results may not be generalizable to the overall diabetes population,
as our study omitted the institutionalised, hospitalised and
housebound.
This study enhances current knowledge on determinants of
HRQoL in patients with diabetes.
Our findings support and strengthen the hypothesis that people
with diabetes are at risk of poor HRQoL; therefore it is an
important outcome measure in diabetes management. To the best
of our knowledge, the unhealthy day’s summary measure has not
been used in patients with diabetes outside of the U. S. and has not
been assessed for agreement with the ADDQoL instrument. Our
study adds to the growing body of literature on the use of the
unhealthy days summary measure. Further clinical and commu-
nity based cross-sectional studies, possibly in tandem with
Figure 1. Distribution of ADDQoL score by unhealthy days groups. Figure 1 shows the variability of the ADDQoL score within the
dichotomised unhealthy day’s groups. While the distribution of the ADDQoL scores was shifted to lower levels in those with one or more unhealthy
days relative to those with none, there was significant overlap between the two groups.
doi:10.1371/journal.pone.0081102.g001
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qualitative research, are needed as a means to assess and improve
HRQoL in diabetes. With time constraints in clinical practice, the
brevity of the unhealthy days summary measure makes it an
attractive HRQoL measurement tool as part of routine practice.
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